Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia - Concepedia

Concepedia

Publication | Open Access

Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia

DOI Full Paper Access

156

Citations

22

References

2015

Year

Dieter Naber, Karina Hansen, Carlos Forray, Ross A. Baker, Christophe Sapin, Maud Beillat, Timothy Peters-Strickland, Anna‐Greta Nylander, P. Hertel, Henrik Steen Andersen,

Schizophrenia Research

Abstract

Superior improvements on clinician-rated health-related quality of life and a favorable tolerability profile suggest greater overall effectiveness for aripiprazole once-monthly vs paliperidone palmitate. ClinicalTrials.gov identifier:NCT01795547.

References

	Year	Citations

Page 1